Article History
First Online: 12 November 2021
Competing interests
: D.P. receives licensing fees (to patents on which he was an inventor) from, invested in, consults (or on scientific advisory boards or boards of directors) for, lectured (and received a fee) or conducts sponsored research at TAU for the following entities: ART Biosciences, BioNTech RNA Pharmaceuticals, EPM Inc., Earli Inc., lmpetis Biosciences, Kernal Biologics, Newphase Ltd, NLC Pharma Ltd, NeoVac Ltd, Roche, SirTLabs Corporation and Teva Pharmaceuticals Inc. All other authors declare no competing interests.
Free to read: This content has been made available to all.